Regulatory guidelines from the Medicines and Healthcare products Regulatory Agency state that only people classified as clinically obese, with a Body Mass Index (BMI) of more than 30, or those who are overweight (BMI of 27-30) with at least one weight-related health condition such as high blood pressure or type 2 diabetes, will be eligible to receive the drug
ArticlePubMedPMC 3
The diarrhea associated with tirzepatide differs from infectious gastroenteritisit generally lacks fever, severe cramping, or bloody stools
A., DAntuono, A., Tiberi, E., Giordano, L., Pianini, T., & Romagnoli, C
May your electrolytes stay balanced, your energy stay steady, and your GLP-1 results stay on track.
Oral drugs are designated as orange dots, and blue designates the injectable treatments